Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis

Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis

Purpose. Multidrug resistance (MDR) is a major obstacle in chemotherapy of leukemia treatments. In this paper, we investigated Usnea Acid (UA) as MDR reversal agent on hematologic K562/ADR cells via ROS dependent apoptosis. Methods. CCK8 assay was used to measure cell viability rate of K562/ADR. Int...

Full description

Bibliographic Details
Main Authors:	Wenjing Wang, Shubin Niu, Luxin Qiao, Feili Wei, Jiming Yin, Shanshan Wang, Yabo Ouyang, Dexi Chen
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2019/8727935

Similar Items

Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells
by: Li Han, et al.
Published: (2014-01-01)

Retracted: Downregulation of MDR1 Gene by Cepharanthine Hydrochloride Is Related to the Activation of c-Jun/JNK in K562/ADR Cells
by: BioMed Research International
Published: (2016-01-01)

Apoptosis Sensitization by Euphorbia Factor L1 in ABCB1-Mediated Multidrug Resistant K562/ADR Cells
by: Zhong-Zhen Zhao, et al.
Published: (2013-10-01)

Expressions of P-glycoprotein, survivin and CD147 molecules on multidrug resistance leukemic cell line K562/Adr
by: Aoranit Somno, et al.
Published: (2015-09-01)

Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line
by: Aoranit Somno, et al.
Published: (2016-01-01)

Quercetin Induce ROSi Depletion, Impairment the Mitochondrial Function and Apoptosis in K562 and K562/adr Cells
by: Suchart kothan, et al.
Published: (2015-02-01)

Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
by: Pondel Marc D, et al.
Published: (2003-04-01)

Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells
by: Wei Liu, et al.
Published: (2018-11-01)

New potential antiproliferative monophosphoester 2-aminoethyl dihydrogen phosphate in K-562 and K-562 MDR+ leukemia cells
by: TO. Conceição, et al.
Published: (2021-10-01)

Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
by: Shi D, et al.
Published: (2016-11-01)

Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells.
by: Huey-Lan Huang, et al.
Published: (2011-01-01)

The role of CD69 in the cell fate of chronic myelogenous leukemia cell line K562
by: Jung-Chen Li, et al.
Published: (2006)

Investigating anti-tumoral activity of adenine on human chronic myelogenous leukemia cell K-562
by: I-Yin Chen, et al.
Published: (2016)

Prodigiosin induced the caspase-dependent apoptosis in human chronic myelogenous leukemia K562 cell
by: Maryam Niakani, et al.
Published: (2021-01-01)

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)
by: Mahdihe Ghasemi, et al.
Published: (2012-12-01)

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)
by: Mahdihe Ghasemi, et al.
Published: (2012-11-01)

MULTIDRUG RESISTANCE (MDR) OF V. Parahaemolyticus
by: Marlina -
Published: (2015-02-01)

Nucleostemin depletion induces post-G1 arrest apoptosis in chronic myelogenous leukemia K562 cells
by: Negin Gogani, et al.
Published: (2014-03-01)

Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols
by: Gerlo Sarah, et al.
Published: (2010-05-01)

Analysis of ceRNA networks and identification of potential drug targets for drug-resistant leukemia cell K562/ADR
by: Zhaoping Liu, et al.
Published: (2021-05-01)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
by: Aline Wolfensberger, et al.
Published: (2019-11-01)

PEGylated dendritic nanoarchitechture improves mean survival time of BDF1 mice bearing myelogenous k -562 leukemia
by: Ramadoss Karthikeyan, et al.
Published: (2013-01-01)

Taxonomy of the Lichen Genus Usnea in Taiwan
by: Yuan-Min Shen, et al.
Published: (2008)

SDF-1α Reduces Human Natural Killer Cell Cytotoxicity against Chronic Myelogenous Leukemia K562 Cells
by: Alireza Mardomi, et al.
Published: (2019-10-01)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019-07-01)

Multidrug resistance in tumour cells: characterisation of the multidrug resistant cell line K562-Lucena 1
by: VIVIAN M. RUMJANEK, et al.
Published: (2001-03-01)

Cytotoxic effect of Spirulina platensis extracts on human acute leukemia Kasumi-1 and chronic myelogenous leukemia K-562 cell lines
by: Flor Yohana Flores Hernandez, et al.
Published: (2017-01-01)

Molecular Mechanism of Matrine from Sophora alopecuroides in the Reversing Effect of Multi-Anticancer Drug Resistance in K562/ADR Cells
by: Zhi Chen, et al.
Published: (2019-01-01)

Antidermatophytic Activity of the Fruticose Lichen Usnea orientalis
by: Ashutosh Pathak, et al.
Published: (2016-09-01)

Phylogenetic Studies in Usnea (Parmeliaceae) and Allied Genera
by: Articus, Kristina
Published: (2004)

Estudio fitoquímico del liquen usnea sp.
by: Morales Bueno, Patricia, et al.
Published: (2013)

Natural product modulators of multidrug resistance (MDR) in Staphylococcus aureus
by: Oluwatuyi, Moyosoluwa Olurele
Published: (2004)

Population genomic analyses of RAD sequences resolves the phylogenetic relationship of the lichen-forming fungal species Usnea antarctica and Usnea aurantiacoatra
by: Felix Grewe, et al.
Published: (2018-12-01)

Usnea amblyoclada «Barba de piedra» (Ascomycetes liquenizados) en Argentina Usnea amblyoclada «barba de piedra» (lichenized Ascomycetes) in Argentina
by: Juan Manuel Rodriguez, et al.
Published: (2008-12-01)

Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents
by: Senling Feng, et al.
Published: (2020-02-01)

Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
by: Lianrong Xu, et al.
Published: (2019-01-01)

Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
by: Natasha F. Sabur, et al.
Published: (2021-03-01)

Multidrug-resistant (MDR) Staphylococcus aureus in a Maracaibo’s hospital, Venezuela
by: Liliana Gómez-Gamboa, et al.
Published: (2016-08-01)

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer
by: Mariana Alves Reis, et al.
Published: (2020-05-01)

Management of multidrug resistant tuberculosis (MDR-TB) – Monitoring is the key to successful
by: J.S. Akshata, et al.
Published: (2016-04-01)